Discover how weve transformed lives
Published clinical trials have reported substantial average body weight reductions over structured trial windows, which is why retatrutide is frequently referenced in modern metabolic research discussions
PMID: 22682224 | doi:10.1016/j.cmet.2012.04.022 Yoshino J et al
Aromatase inhibitor joint pain Joint pain is the most common reason women stop aromatase inhibitor therapy early, and stopping AI treatment ahead of schedule is associated with higher recurrence risk
Exercise, particularly resistance training, is crucial for preserving lean mass and functional health, especially during weight loss (11, 17, 18)
Modern Applications of GLP-1 Moving Beyond Diabetes GLP-1 therapy options include new multi-target drugs incorporating GLP-1, GIP, and glucagon receptor signalling to provide weight reduction and glycemic regulation that mimic the outcomes achieved through surgery